A DNA-based test can be effective in identifying women with potentially or mildly abnormal cervical smear who are at a high risk of having precursors of cervical cancer, a new Cochrane systematic review reveals. The authors found that the DNA-based test identified patients in possible need of treatment more accurately than a repeat smear test. Cervical smear ("Pap") tests are carried out to identify women who might be at high risk of developing cervical ...
via Medindia Health News More READ
No comments:
Post a Comment